Skip to content
Tejnaksh Healthcare logo

Tejnaksh Healthcare

539428 BSE
₹12.83

Close ·

P/E
21.03
View as Markdown
MCP
Close 4 Nov 2026 ₹12.83 −4.26 −24.9% 1Y
Start ₹17.09

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures at the close · EPS basis: Consolidated · TTM

ROCE
6.35%
Debt to Equity
0.01
EPS (TTM)
₹0.61
Book Value
₹13.36
Market Cap
—
P/E (TTM)
21.03
P/B
0.96
ROE
4.67%
Dividend Yield
0.00%
EBITDA
₹3.20 Cr
52W High
₹18.60
52W Low
₹10.65

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

Overall score

55 Good

Data confidence 98/100

Category scores

Quality
70
Strong
Returns, margins, earnings quality 22% weight
Valuation
61
Good
Cheap vs sector & own history 24% weight
Growth
21
Poor
Sales & profit trajectory 9% weight
Financial Health
78
Strong
Solvency, leverage, coverage 9% weight
Momentum
33
Poor
Trend strength, vol-adjusted 12% weight
Ownership
50
Average
FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Stock is trading at 0.94 times its book value

Weaknesses

5
  • Though the company is reporting repeated profits, it is not paying out dividend
  • The company has delivered a poor sales growth of -2.50% over past five years.
  • Company has a low return on equity of 7.24% over last 3 years.
  • Debtor days have increased from 48.0 to 75.5 days.
  • Working capital days have increased from 59.0 days to 91.8 days

Technical Indicators

Technical signals: verdict and indicator counts
GroupSignalBearishNeutralBullish
OverallBearish775
OscillatorsNeutral171
Moving AveragesStrong Bearish604

Key readings

RSI (14)
50.75
Neutral
MACD (12,26,9)
−0.12
Bullish
SMA (50)
13.11
Bearish
SMA (200)
14.03
Bearish

As of

Growth Rate

From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
10Y+8.30%
5Y−2.50%
3Y−3.50%
1Y−17.33%
TTM−12.97%

Net profit

Net profit growth by window
10Y−1.11%
5Y−10.63%
3Y−12.97%
1Y−47.09%
TTM−33.70%

Operating cash flow

Operating cash flow growth by window
10Y−7.30%
5Y+7.83%
3Y−6.73%
1Y+616.67%
TTM—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
10Y−21.85 pp
5Y−4.53 pp
3Y−4.97 pp
1Y−5.59 pp
TTM−2.61 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2017₹7.28 Cr
Mar 2018₹14.14 Cr
Mar 2019₹19.76 Cr
Mar 2020₹17.12 Cr
Mar 2021₹11.96 Cr
Mar 2022₹12.68 Cr
Mar 2023₹11.73 Cr
Mar 2024₹12.18 Cr
Mar 2025₹12.75 Cr
Mar 2026₹10.54 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2017₹1.82 Cr
Mar 2018₹3.18 Cr
Mar 2019₹3.14 Cr
Mar 2020₹2.15 Cr
Mar 2021₹2.07 Cr
Mar 2022₹2.81 Cr
Mar 2023₹1.79 Cr
Mar 2024₹1.77 Cr
Mar 2025₹2.23 Cr
Mar 2026₹1.18 Cr

Quarterly Results

₹ Cr
539428 quarterly results, ₹ crore
Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
3.03
3.09
3.14
2.92
3.12
3.37
3.19
3.21
2.64
2.98
2.62
2.55
2.65
Expenses
2.51
1.96
2.07
2.01
2.04
2.21
2.05
2.5
2.04
2.21
1.93
1.84
1.96
Operating Profit
0.52
1.13
1.07
0.91
1.08
1.16
1.14
0.71
0.6
0.77
0.69
0.71
0.69
OPM %
17.16%
36.57%
34.08%
31.16%
34.62%
34.42%
35.74%
22.12%
22.73%
25.84%
26.34%
27.84%
26.04%
Other Income
0.08
0.08
0.07
0.07
0.07
0.09
0.17
0.07
0.09
0.09
0.07
0.14
0.1
Interest
0.16
0.16
0.19
0.14
0.12
0.11
0.14
0.01
0.05
0.03
0.04
−0.03
0.01
Depreciation
0.23
0.23
0.23
0.23
0.23
0.31
0.2
0.17
0.36
0.35
0.36
0.36
0.35
PBT
0.21
0.82
0.72
0.61
0.8
0.83
0.97
0.6
0.28
0.48
0.36
0.52
0.43
Tax %
28.57%
26.83%
25%
26.23%
25%
21.69%
42.27%
28.33%
28.57%
33.33%
19.44%
32.69%
37.21%
Net Profit
0.16
0.61
0.54
0.46
0.6
0.65
0.56
0.42
0.21
0.33
0.28
0.35
0.26
EPS (₹)
0.08
0.29
0.27
0.25
0.3
0.31
0.3
0.25
0.12
0.15
0.15
0.18
0.13

Profit & Loss

₹ Cr
539428 profit and loss, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
4.75
7.28
14.14
19.76
17.12
11.96
12.68
11.73
12.18
12.75
10.54
10.8
Expenses
2.45
4.08
8.8
15.58
13.08
8.24
7.88
8.03
8.55
8.65
7.74
7.94
Operating Profit
2.3
3.2
5.34
4.18
4.04
3.72
4.8
3.7
3.63
4.1
2.8
2.86
OPM %
48.42%
43.96%
37.77%
21.15%
23.6%
31.1%
37.85%
31.54%
29.8%
32.16%
26.57%
26.48%
Other Income
0.03
0.19
0.39
1.55
0.34
0.13
0.11
0.31
0.31
0.4
0.38
0.4
Interest
0
0.2
0.98
0.78
0.76
0.5
0.48
0.62
0.66
0.4
0.11
0.05
Depreciation
0.21
0.35
0.47
0.59
0.65
0.68
0.67
0.87
0.91
0.91
1.43
1.42
PBT
2.12
2.84
4.28
4.36
2.97
2.67
3.76
2.52
2.37
3.19
1.64
1.79
Tax %
37.74%
32.75%
25.7%
28.21%
27.61%
22.47%
25.27%
28.57%
25.74%
30.09%
28.05%
—
Net Profit
1.32
1.82
3.18
3.14
2.15
2.07
2.81
1.79
1.77
2.23
1.18
1.22
EPS (₹)
0.65
0.9
1.42
1.49
1.03
1.01
1.34
0.83
0.88
1.15
0.61
0.61
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—

Balance Sheet

₹ Cr
539428 balance sheet, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
1.1
2.21
2.21
10.16
10.16
10.16
10.16
10.16
10.16
10.16
10.16
Reserves
5.14
5.86
7.93
3
5.09
7.16
9.9
11.61
13.41
15.75
16.99
Borrowings
0
6.39
7.64
6.33
7.19
4.89
6.99
6.42
4.8
1.05
0.25
Other Liabilities
0.6
1.07
1.98
2.78
2.47
2.36
2.56
3.04
2.99
3.35
2.65
Total Liabilities
6.84
15.53
19.76
22.27
24.91
24.57
29.61
31.23
31.36
30.31
30.05
Fixed Assets
3.34
13.6
15.33
16.97
17.37
15.04
15.38
23.42
23.22
21.16
20.23
CWIP
0
0
0
0.39
0.65
0.79
8.89
0.95
1.07
1.33
1.69
Investments
2.59
0.01
0
0
0
0
0
0
0
0
0
Other Assets
0.91
1.92
4.43
4.91
6.89
8.74
5.34
6.86
7.07
7.82
8.13
Total Assets
6.84
15.53
19.76
22.27
24.91
24.57
29.61
31.23
31.36
30.31
30.05

Cash Flow

₹ Cr
539428 cash flow, annual, ₹ crore
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
3.67
2.25
4.49
3.15
1.16
1.18
9.21
2.12
4.01
0.24
1.72
Investing
−3.26
−8.03
−3.24
−1.55
−1.21
1.56
−10.59
−1.4
−1.01
3.66
−0.28
Financing
−0.13
6.43
−0.66
−2.09
0.1
−2.8
1.62
−1.2
−2.27
−3.87
−1.24
Net Cash Flow
0.29
0.65
0.59
−0.5
0.05
−0.06
0.24
−0.48
0.73
0.03
0.19
Free Cash Flow
2.99
−8.36
3
1.58
−0.15
2.68
0.09
1.19
3.18
1.12
1.21
CFO/OP
160
70
104
94
41
13
187
46
120
17
91

Ratios

539428 financial ratios, annual
Particulars Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
0
0
—
3.51
11.3
14.34
16.41
49.16
15.58
52.96
75.49
Inventory Days
98.06
130
221
255
180
284
185
173
233
224
297
Days Payable
114
226
227
184
152
191
100
140
63.23
84.88
85.88
Cash Conversion Cycle
−16.34
−95.6
—
74.06
39.38
108
101
82.82
185
192
287
Working Capital Days
−1.54
4.51
−42.85
19.4
75.47
8.55
6.62
44.5
3.3
81.87
91.77
ROCE %
—
29.19%
32.23%
27.11%
17.45%
13.97%
17.03%
11.13%
10.48%
12.71%
6.35%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Tejnaksh Healthcare insights

61 extracted metrics across FY15–FY27.

Shareholding Pattern

As of Sep 2026

  • Promoters 73.83%
  • Public 23.53%
  • Others 2.64%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Not shown for some quarters: Others. Not available separately for this quarter: the shareholding filing gives Public and Others as one figure, shown under Public, so Others is left blank rather than estimated.

Documents

  • Concall · Feb 2018
    PPT

Frequently Asked Questions about Tejnaksh Healthcare

What does Tejnaksh Healthcare Ltd do?
Incorporated in 2008, Tejnaksh Healthcare Ltd is in the business of Healthcare Services and Pharmacies
Where is Tejnaksh Healthcare Ltd (TEJNAKSH) listed?
Tejnaksh Healthcare Ltd trades under code 539428 on the BSE.
Which sector does Tejnaksh Healthcare Ltd belong to?
Tejnaksh Healthcare Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the PE ratio of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd trades at a PE ratio of 21.03 as of 4 Nov 2026, on earnings per share of ₹0.61, against a book value of ₹13.36 per share.
What is the 52-week high and low of Tejnaksh Healthcare Ltd?
Over the last 52 weeks Tejnaksh Healthcare Ltd has traded between ₹10.65 and ₹18.6 as of 4 Nov 2026.
What is the Return on Equity (ROE) of Tejnaksh Healthcare Ltd?
Tejnaksh Healthcare Ltd reported a return on equity of 4.67%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 2008, Tejnaksh Healthcare Ltd is in the business of Healthcare Services and Pharmacies

Website tejnaksh.com
Listed 27 Oct 2015
Face Value ₹5

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539428.md for Tejnaksh Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month